The role of vitamin K in cholestatic liver disease

Halima Sultana, Michio Komai, Hitoshi Shirakawa

Research output: Contribution to journalReview articlepeer-review

16 Citations (Scopus)


Vitamin K (VK) is a ligand of the pregnane X receptor (PXR), which plays a critical role in the detoxification of xenobiotics and metabolism of bile acids. VK1 may reduce the risk of death in patients with chronic liver failure. VK deficiency is associated with intrahepatic cholestasis, and is already being used as a drug for cholestasis-induced liver fibrosis in China. In Japan, to treat osteoporosis in patients with primary biliary cholangitis, VK2 formulations are prescribed, along with vitamin D3. Animal studies have revealed that after bile duct ligation-induced cholestasis, PXR knockout mice manifested more hepatic damage than wild-type mice. Ligand-mediated activation of PXR improves biochemical parameters. Rifampicin is a well-known human PXR ligand that has been used to treat intractable pruritus in severe cholestasis. In addition to its anti-cholestatic properties, PXR has anti-fibrotic and anti-inflammatory effects. However, because of the scarcity of animal studies, the mechanism of the effect of VK on cholestasis-related liver disease has not yet been revealed. Moreover, the application of VK in cholestasis-related diseases is controversial. Considering this background, the present review focuses on the effect of VK in cholestasis-related diseases, emphasizing its function as a modulator of PXR.

Original languageEnglish
Article number2515
Issue number8
Publication statusPublished - 2021 Aug


  • Bile acid metabolism
  • Cholestasis
  • Pregnane X receptor
  • Vitamin K


Dive into the research topics of 'The role of vitamin K in cholestatic liver disease'. Together they form a unique fingerprint.

Cite this